Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Jun 2026 for National Healthcare CORP.
Filing timeline
BuySaleRobert G. Adams
Insider track record
Disclosed buys
9
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Robert G. Adams: trading record in brief
Robert G. Adams (board member) discloses dealings in 2 companies, chiefly National Healthcare Corp and National Health Investors Inc. In total, 32 filings cover trades dated from 22 February 2016 to 8 June 2026.
Every open-market trade on record is a purchase: 9 purchases worth €909k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants and 17 option exercises.
A typical purchase (the median) is worth €101k. Of 9 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 10 June 2026: an option exercise, in National Healthcare Corp. The clock since the last published purchase (14 September 2023) now reads 1,135 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert G. Adams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
4,000 sharesShares of Common Stock - Trust ISEC:0001437749-26-020163:0
4,000 sharesShares of Common Stock - Trust ISEC:0001437749-26-020163:1
25,000 shares@ US$69.2023.3% of flowCommon StockSEC:0000877860-26-000010:0
4,500 shares@ US$71.6420.0% of flowShares of Common Stock - Trust ISEC:0001437749-25-029735:0
10,000 shares@ US$54.7310.3% of flowCommon StockSEC:0001127602-25-010799:1
32,935 shares@ US$74.7046.4% of flowCommon StockSEC:0001127602-25-010799:3
25,000 shares@ US$53.4125.2% of flowCommon StockSEC:0001127602-25-010799:0
10,000 shares@ US$57.7610.9% of flowCommon StockSEC:0001127602-25-010799:2
3,000 shares@ US$71.6414.3% of flowShares of Common Stock - Trust ISEC:0001437749-24-026868:0
7,500 shares@ US$77.9238.9% of flowShares of Common Stock - Trust ISEC:0001437749-23-034763:0
85,411 shares0Common StockSEC:0001127602-23-026742:0
2,000 shares@ US$66.96189.1% of flowShares of Common Stock - Trust ISEC:0001437749-23-025905:0
Canonical exit: 5 Dec 2023 (T+90)
2,000 shares@ US$65.408.9% of flowShares of Common Stock - Trust ISEC:0001437749-23-025396:0
Canonical exit: 5 Dec 2023 (T+90)
1,000 shares@ US$56.601.1% of flowCommon StockSEC:0001127602-22-027591:0
Canonical exit: 14 Mar 2023 (T+90)
1,500 shares@ US$65.932.0% of flowCommon StockSEC:0001127602-22-021006:0
Canonical exit: 13 Nov 2022 (T+90)
1,934 shares@ US$64.648.7% of flowShares of Common Stock - PartnershipSEC:0001437749-22-013037:0
2,000 shares@ US$57.251.6% of flowCommon StockSEC:0001127602-22-000520:0
Canonical exit: 30 Mar 2022 (T+90)
17 of 17 declarations
